Application 065414
- Type
- ANDA
- Sponsor
- ACS DOBFAR
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEFOXITIN | CEFOXITIN SODIUM | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | No | Yes |
| 002 | CEFOXITIN | CEFOXITIN SODIUM | INJECTABLE;INJECTION | EQ 2GM BASE/VIAL | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065414-001 | CEFOXITIN | CEFOXITIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 |
| A065414-002 | CEFOXITIN | CEFOXITIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A065414-001 | AP |
| A065414-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A065414-001 | CEFOXITIN | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A065414-002 | CEFOXITIN | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2009-06-12 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A065414-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A065414-002 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065414-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065414-002 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A065414-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A065414-002 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065414-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065414-002 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065414-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065414-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065414-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065414-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065414-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065414-002 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065414-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065414-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065414-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065414-002 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A065414-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A065414-002 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065414-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065414-002 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065414-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065414-002 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065414-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065414-002 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A065414-001 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A065414-002 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065414-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065414-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A065414-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A065414-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A065414-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A065414-002 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A065414-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A065414-002 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A065414-001 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A065414-002 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A065414-001 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A065414-002 | AP | 1 | 782e0a99824c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefoxitin | CEFOXITIN | WG Critical Care, LLC | 91ac4c14-8dd8-4efe-a462-d1c488a6184f | 2025-11-12 | Warnings, Adverse reactions | 065414 ANDA065414 44567-245 44567-246 |
| Cefoxitin | CEFOXITIN | Sagent Pharmaceuticals | b272ef9c-4d83-4ee2-b9cc-477440822cca | 2024-01-03 | Warnings, Adverse reactions | 065414 ANDA065414 25021-109 25021-110 |
| Cefoxitin | CEFOXITIN | WG Critical Care, LLC | 658a0dc6-6da5-44dc-94f2-1211619297f7 | 2023-10-18 | Warnings, Adverse reactions | 065414 ANDA065414 44567-245 44567-246 |
| Cefoxitin | CEFOXITIN SODIUM | Fresenius Kabi USA, LLC | 2a9d1e7b-96ee-4e6c-a1e8-47b76b924422 | 2023-07-10 | Warnings, Adverse reactions | 065414 ANDA065414 63323-341 63323-342 |
| Cefoxitin | CEFOXITIN SODIUM | Fresenius Kabi USA, LLC | d02170ff-65aa-48b8-a922-94271c46ffa7 | 2022-09-23 | Warnings, Adverse reactions | 065414 ANDA065414 63323-341 63323-342 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 25021-109 | Cefoxitin | cefoxitin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-109 | Cefoxitin | cefoxitin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-109 | Cefoxitin | cefoxitin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-109 | Cefoxitin | cefoxitin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-110 | Cefoxitin | cefoxitin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-110 | Cefoxitin | cefoxitin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-110 | Cefoxitin | cefoxitin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-110 | Cefoxitin | cefoxitin | Sagent Pharmaceuticals | ANDA | Current |
| 44567-245 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 44567-245 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 44567-245 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 44567-245 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 44567-245 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 44567-245 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 44567-245 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 44567-245 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 44567-246 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 44567-246 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 44567-246 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 44567-246 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 44567-246 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 44567-246 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 44567-246 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 44567-246 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 63323-341 | Cefoxitin | Cefoxitin Sodium | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-341 | Cefoxitin | Cefoxitin Sodium | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-341 | Cefoxitin | Cefoxitin Sodium | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-341 | Cefoxitin | Cefoxitin Sodium | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-341 | Cefoxitin | Cefoxitin Sodium | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-341 | Cefoxitin | Cefoxitin Sodium | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-341 | Cefoxitin | Cefoxitin Sodium | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-341 | Cefoxitin | Cefoxitin Sodium | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-342 | Cefoxitin | Cefoxitin Sodium | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-342 | Cefoxitin | Cefoxitin Sodium | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-342 | Cefoxitin | Cefoxitin Sodium | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-342 | Cefoxitin | Cefoxitin Sodium | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-342 | Cefoxitin | Cefoxitin Sodium | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-342 | Cefoxitin | Cefoxitin Sodium | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-342 | Cefoxitin | Cefoxitin Sodium | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-342 | Cefoxitin | Cefoxitin Sodium | Fresenius Kabi USA, LLC | ANDA | Current |